scholarly article | Q13442814 |
P50 | author | Jane Goodall | Q57195861 |
P2093 | author name string | Gurman Kaur | |
J. S. Hill Gaston | |||
Lorna B. Jarvis | |||
P2860 | cites work | Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse | Q24290693 |
FOXP3 controls regulatory T cell function through cooperation with NFAT | Q24298179 | ||
Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells | Q24298812 | ||
FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression | Q24300168 | ||
Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor | Q24300325 | ||
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1 | Q24300625 | ||
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells | Q24306205 | ||
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function | Q24314628 | ||
Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3 | Q24315715 | ||
Foxp3 occupancy and regulation of key target genes during T-cell stimulation | Q24623384 | ||
JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome | Q24626901 | ||
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells | Q24645614 | ||
Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat | Q39988736 | ||
Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3. | Q40055892 | ||
FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. | Q40116369 | ||
Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production | Q40165347 | ||
Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. | Q40339083 | ||
Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. | Q40801370 | ||
The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. | Q41998069 | ||
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo | Q42139164 | ||
Molecular mechanisms underlying FOXP3 induction in human T cells | Q42491664 | ||
Regulatory T cell development in the absence of functional Foxp3. | Q44440268 | ||
Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity | Q47265853 | ||
Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. | Q51997055 | ||
IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. | Q51998742 | ||
DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. | Q52924279 | ||
Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function. | Q54641462 | ||
Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. | Q54645452 | ||
Human leukocyte antigen class I-restricted immunosuppression by human CD8+ regulatory T cells requires CTLA-4-mediated interaction with dendritic cells | Q56900343 | ||
Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells | Q58234949 | ||
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression | Q59048389 | ||
Foxp3-dependent programme of regulatory T-cell differentiation | Q59084714 | ||
Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level | Q60311694 | ||
Foxp3 Transcription-Factor-Dependent and -Independent Regulation of the Regulatory T Cell Transcriptional Signature | Q61713917 | ||
Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation | Q79147744 | ||
Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells | Q81083994 | ||
Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice | Q84925181 | ||
Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome | Q24679039 | ||
HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells | Q24802813 | ||
Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3 | Q28116303 | ||
The amount of scurfin protein determines peripheral T cell number and responsiveness | Q28504592 | ||
Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 | ||
Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 | Q28591451 | ||
An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy | Q29619109 | ||
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 | Q29619324 | ||
Epigenetic control of the foxp3 locus in regulatory T cells | Q33273617 | ||
FOXP3 promoter demethylation reveals the committed Treg population in humans. | Q33320522 | ||
The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome | Q33404650 | ||
Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery | Q33414811 | ||
Domain requirements and sequence specificity of DNA binding for the forkhead transcription factor FOXP3 | Q33517120 | ||
c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells | Q33590483 | ||
Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells | Q33810601 | ||
De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells | Q33932462 | ||
Five years on the wings of fork head | Q34398426 | ||
Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. | Q34529123 | ||
FOXP3 and NFAT: partners in tolerance | Q34551714 | ||
Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development | Q34597933 | ||
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer | Q34729938 | ||
Nonredundant roles for Stat5a/b in directly regulating Foxp3 | Q35828667 | ||
X-linked lymphoreticular disease in the scurfy (sf) mutant mouse | Q35831357 | ||
Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype | Q36059631 | ||
CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. | Q36229540 | ||
FOXP3: of mice and men. | Q36427333 | ||
Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells | Q37394198 | ||
Fatal lymphoreticular disease in the scurfy (sf) mouse requires T cells that mature in a sf thymic environment: potential model for thymic education | Q37537286 | ||
AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. | Q37636349 | ||
Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. | Q38305613 | ||
Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease | Q38306073 | ||
CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells | Q39333442 | ||
P433 | issue | 1-3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 321-332 | |
P577 | publication date | 2010-08-05 | |
P1433 | published in | Molecular Immunology | Q6895954 |
P1476 | title | Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells | |
Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells—Identification of Foxp3Δ7 in human regulatory T cells | |||
P478 | volume | 48 |
Q38779090 | Activation-dependent mitochondrial translocation of Foxp3 in human hepatocytes |
Q55495606 | Alternative Splicing of FOXP3-Virtue and Vice. |
Q52966824 | C-terminal cleavage of human Foxp3 at a proprotein convertase motif abrogates its suppressive function. |
Q38319204 | ChIP-on-chip analysis identifies IL-22 as direct target gene of ectopically expressed FOXP3 transcription factor in human T cells |
Q36751866 | Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn |
Q34778974 | Dissecting the role of the FOXP3 gene in the joint genetic susceptibility to autoimmune thyroiditis and diabetes: a genetic and functional analysis |
Q36904140 | Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants |
Q35206452 | Inactivation of X-linked tumor suppressor genes in human cancer |
Q46439239 | Metabolic pressure and the breach of immunological self-tolerance. |
Q38439401 | Metabolism of murine TH 17 cells: Impact on cell fate and function |
Q92757833 | One, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity |
Q58574940 | Regulatory T Cells and Profile of FOXP3 Isoforms Expression in Peripheral Blood of Patients with Myelodysplastic Syndromes |
Q45846238 | Regulatory T cell proliferative potential is impaired in human autoimmune disease |
Q38957379 | Role of Metabolism in the Immunobiology of Regulatory T Cells |
Q24337573 | Subcellular localization of FOXP3 in human regulatory and nonregulatory T cells |
Q90176770 | The Impact of Dietary Components on Regulatory T Cells and Disease |
Q37864831 | The dual role of the X-linked FoxP3 gene in human cancers |
Q48010811 | The regulation of immune tolerance by FOXP3. |
Search more.